IHR Emergency Committee on COVID-19 urges focus on evidence-based response efforts

The Emergency Committee on COVID-19 met on 29 October to review the situation and progress made on the temporary recommendations. They advised that the pandemic still constituted a public health emergency of international concern, and urged a focus on response efforts based on lessons learned and strong science.

WHO Director-General Dr Tedros Adhanom Ghebreyesus accepted the advice of the committee, stating that "WHO will continue to work in partnership across the world to drive science, solutions and solidarity."

The committee expressed appreciation for WHO's leadership and activities throughout the global response, including its critical role in developing evidence-based guidance, providing countries with technical assistance and critical supplies and equipment, communicating clear information and addressing misinformation, and convening the Solidarity Trials and the Access to COVID-19 Tools (ACT) Accelerator.

The committee provided concrete and targeted advice for WHO and countries to focus on in the coming months. It emphasized the importance of evidence-informed, risk-based and coherent measures in relation to international traffic, surveillance and contract tracing efforts, maintaining essential health services including mental health services, and preparing plans for future COVID-19 vaccines. The committee urged countries to avoid politicization of the pandemic response, seen as a major detriment to global efforts. Read the full statement.

As the committee convened for the fifth time, global reported cases had reached 44 million, with over 1.1 million people having lost their lives to COVID-19.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Link between COVID-19 and long-term risk of autoimmune and autoinflammatory connective tissue disorders